Cargando…

Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins

Endometriosis is a chronic inflammatory disease that occurs in women of reproductive age. Much of the treatment involves hormone therapy that suppresses the proliferation of endometriosis lesions. Objective To compare discontinuation rates of pharmacological treatment with estrogen-progestins and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Costa Pinheiro, Denise Joffily Pereira, Pereira, Ana Maria Gomes, Antonini, Marcelo, Maria Albuquerque Salgado, Isabella, Dias, Alexandre Torchio, Lopes, Reginaldo Guedes Coelho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517511/ https://www.ncbi.nlm.nih.gov/pubmed/37741998 http://dx.doi.org/10.1186/s12905-023-02647-y

Ejemplares similares

Does Pink October really impact breast cancer screening?
por: Antonini, Marcelo, et al.
Publicado: (2022)

Female Sexual Function in Women with Suspected Deep Infiltrating Endometriosis
por: Lima, Ryane Vieira, et al.
Publicado: (2018)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
por: Matasariu, Daniela Roxana, et al.
Publicado: (2023)

Effects of hormonal contraceptive phase and progestin generation on stress-induced cortisol and progesterone release
por: Herrera, Alexandra Ycaza, et al.
Publicado: (2019)

The Impact of Progestin-only Contraception on Adolescents with Macromastia
por: Nuzzi, Laura C., et al.
Publicado: (2021)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

Hysteroscopic sterilization of patient with intrauterine device Mirena(®)
por: Depes, Daniella De Batista, et al.
Publicado: (2013)

Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety
por: Mitchell, Jon-Benay, et al.
Publicado: (2022)

Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study
por: Bula, Agatha K., et al.
Publicado: (2021)

Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans
por: Sarna, Magdalena A., et al.
Publicado: (2009)

Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception
por: Eriksson, Karin, et al.
Publicado: (2020)

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation
por: Shamseddin, Marie, et al.
Publicado: (2021)

The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control—plus more
por: Shoupe, Donna
Publicado: (2023)

Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission
por: Buckner, Lyndsey R., et al.
Publicado: (2019)

A rodent model of human dose-equivalent progestin-only implantable contraception
por: Allaway, Heather C. M., et al.
Publicado: (2021)

Enhanced ZBTB16 Levels by Progestin-Only Contraceptives Induces Decidualization and Inflammation
por: Arlier, Sefa, et al.
Publicado: (2023)

Amniotic Sludge and Prematurity: Systematic Review and Meta-analysis
por: Pannain, Gabriel Duque, et al.
Publicado: (2023)

Initial experience with hysteroscopic tubal occlusion (Essure(®))
por: Depes, Daniella De Batista, et al.
Publicado: (2016)

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa
por: Noguchi, Lisa M., et al.
Publicado: (2021)

Partial ablation of endometrial glands in dogs after exposure to progestin during the neonatal period
por: Teixeira, Natália Soares, et al.
Publicado: (2018)

Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner Syndrome patients
por: Mathez, Andréia Latanza Gomes, et al.
Publicado: (2020)

Axillary lymph nodes in breast cancer patients: sonographic evaluation
por: Pinheiro, Denise Joffily Pereira da Costa, et al.
Publicado: (2014)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
por: Liang, Zhou, et al.
Publicado: (2020)

Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain
por: Maia, Hugo, et al.
Publicado: (2012)

Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review
por: Graziottin, Alessandra
Publicado: (2008)

Systematic Review of Nomograms Used for Predicting Pathological Complete Response in Early Breast Cancer
por: Antonini, Marcelo, et al.
Publicado: (2023)

Progestin-only contraception is first line for sickle cell disease: a comment on “Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.”
por: Pecker, Lydia H., et al.
Publicado: (2023)

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)

The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy
por: Cezar, TC, et al.
Publicado: (2018)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial
por: Khalifa, Eissa, et al.
Publicado: (2021)

Author Correction: Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner Syndrome patients
por: Mathez, Andréia Latanza Gomes, et al.
Publicado: (2020)

Intercellular adhesion molecule-1 expression in human endometrium: implications for long term progestin only contraception
por: Schatz, Frederick, et al.
Publicado: (2006)

Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
por: Mantha, S, et al.
Publicado: (2012)

Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis
por: Glisic, Marija, et al.
Publicado: (2018)

Drospirenone/ethinyl estradiol 3 mg/20 μg (24/4 day regimen): hormonal contraceptive choices – use of a fourth-generation progestin
por: Bachmann, Gloria, et al.
Publicado: (2009)

The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment’ for endometriosis-related pain: An economic evaluation
por: Grand, Tobias Sydendal, et al.
Publicado: (2019)

The many faces of endometriosis
por: de Souza, Marcelo Luis Pereira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0s9daiu5j0c3nqfp3c75ir4enj